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Treatment uptake by individuals infected with Plasmodium
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Objective To find out what proportion of Plasmodium falciparum infections are treated in rural Gambia.
Methods Subjects from four villages in the Gambia were followed over nine months through visits to village health workers. Monthly
cross-sectional malaria surveys measured the prevalence of P. falciparum infection. Linked databases were searched for treatment
requests. Treated cases were individuals with parasitaemia who requested treatment during narrow or extended periods (14 or 28 days,
respectively) before or after a positive blood film was obtained.
Findings Parasite prevalence peaked in November 1998, when 399/653 (61%) individuals had parasitaemia. Parasite prevalence was
highest throughout the study in children aged 5–10 years. Although access to treatment was better than in most of sub-Saharan Africa,
only 20% of infected individuals sought medical treatment up to 14 days before or after a positive blood film. Within two months of a
positive blood film, 199/726 (27%) individuals with parasitaemia requested treatment. Despite easy access to health care, less than half
(42%) of those with parasite densities consistent with malaria attacks (>5000/ml) requested treatment. High parasite density and
infection during October–November were associated with more frequent treatment requests. Self-treatment was infrequent in study
villages: in 3/120 (2.5%) households antimalarial drugs had been used in the preceding malaria season.
Conclusion Many P. falciparum infections may be untreated because of their subclinical nature. Intermittent presumptive treatment
may reduce morbidity and mortality. It is likely that not all untreated infections were asymptomatic. Qualitative research should explore
barriers to treatment uptake, to allow educational interventions to be planned.
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Introduction
Plasmodium falciparum infections are responsible for more than
200 million episodes of clinical malaria, which result in at least
onemillion deaths per year (1). Since early effective treatment of
malaria can reducemorbidity andmortality, case management at
primary health centres is a main component of current malaria
control strategies (2). The antimalarial drugs used most widely
for case management in sub-Saharan Africa, chloroquine and
pyrimethamine plus sulfadoxine (Fansidar), have little effect on
gametocytes. Gametocytes, the sexual form of P. falciparum, do
not cause symptoms, but they do infect mosquitoes during the
blood meal and are thus essential for the completion of the life
cycle of the parasite. It has been suggested that the introduction
and widespread use of antimalarial drugs that have a suppressive
effect on gametocytes, such as artemisinin derivatives, can
decrease transmission of malaria.
In northern Thailand, artemisinin derivatives were
introduced to improve case management of malaria strains
resistant to multiple drugs. After widespread use of the
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artemisinin derivatives, malaria incidence decreased signifi-
cantly (3). Artemisinin derivatives are cheap, safe and highly
effective against sexual and asexual parasites and, therefore, are
an attractive option for malaria control (4). The effect of case
management on malaria transmission, however, also depends
on the proportion of infections treated. In Thailand, a country
with low malaria transmission, most infections are sympto-
matic, treatment uptake is high and most infections are treated
(5). In sub-Saharan Africa, malaria transmission is much
higher, more individuals are exposed to P. falciparum infections,
more infections are asymptomatic and the proportion of
P. falciparum infections that are treated is usually unknown.
To have an effect on transmission, the prevalence of
gametocytes has to be reduced below a critical threshold. Case
management represents an attractive way to distribute drugs
because of the pre-existing, widely accepted infrastructure, but
it can only reduce malaria transmission if a high proportion of
P. falciparum-infected individuals seek treatment. As part of a
programme to investigate the potential of drug treatment to
reduce malaria transmission, we carried out a study to quantify
the proportion of P. falciparum infections likely to be treated
under optimal circumstances in a rural Gambian community.
Methods
Setting
The Gambia has a population of about 1.4 million, and more
than half live in rural settings. Four villages were chosen by the
district health team as being representative of the socio-
economic status and ethnic composition of rural Gambia. The
study villages were within a 50 km radius of Farafenni — the
administrative centre of the district. Yallal is 11km to the west
of Farafenni, where the nearest health centre and pharmacies
are found. Villagers from the other three villages — Kumbija,
Kani Kunda and Bambali — have to travel 15–25 km to the
nearest health centre and dispensary in Ngeyen Sanjal. Before
the start of the study, the census of each village was updated,
and every villager was assigned a unique census number. The
study villages were on the north bank of the river Gambia,
170 km east of the Atlantic coast. The climate in the chosen
study area was characterised by seasonal rainfall between
August and October. Agriculture is the only source of income
for most villagers.
Treatment of malaria in study villages
All four villages have a primary health care worker whose
responsibilities include the treatment of cases of malaria.
During the study, drugs were offered free of charge to all
individuals seeking treatment from the village health worker.
For the study period, field workers helped the village health
workers to diagnose and treat cases of malaria. Before they
were posted to study villages, fieldworkers were trained to use a
rapid parasite-detection test and to recognize and treat
uncomplicated malaria. After fieldworkers were assigned a
post, they stayed in that village for at least six days a week.
Every individual who presented with a history of fever
was tested for P. falciparum infection using a rapid diagnostic
test (ICTMalaria Pf; ICTDiagnostics, Sydney, Australia), and a
blood film was obtained. Individuals who tested positive for P.
falciparum infection using the rapid diagnostic test were treated
immediately with a three-day course of chloroquine, in
accordance with the Gambian government’s guidelines. The
first dose was given under direct supervision. Individuals who
presented without evidence of malaria and those who did not
improve when taking chloroquine were referred to a health
centre. Each requested treatment was entered into a
computerized database, and the individual was identified by
his or her census number.
Estimating parasite prevalence
In order to determine the proportion of parasite infections that
led to a request for treatment, 150 residents in each of the four
villages were selected using computer-generated random
numbers. Between September 1998 and May 1999, these
individuals were asked to provide a thick blood film once a
month. Fieldworkers tried to obtain repeat samples from the
same individuals. Participants who were absent or refused to
give a blood sample were replaced with those of a similar age
from the same compound. The results of the blood films were
explained to the participants during the next visit. Free
treatment was offered at that time, if it had not been given
previously. The blood film results were entered in data files, in
which each individual was identified by his or her census
number.
Estimating home treatment
In each village, 30 randomly selected household heads were
asked at the end of the malaria season whether they had
purchased any medication during the preceding season and
whether they kept any medication in the house. If the answer
was yes, the drug names were recorded. In addition, all
shopkeepers in the four villages were asked which antimalarial
drugs they had in store at the time of the visit or had stocked
during the preceding malaria season.
Laboratory methods
Thick blood films were left to dry for a minimum of 24 hours
andwere stained withGiemsa stain. The slides were stored and
read during the next month. One experienced microscopist
read 50 high power fields on a thick film. All categorization of
individuals as infected or uninfected was based on blood film
results. Parasite density was estimated on the assumption that
one parasite per high power field equals 500 parasites per
microlitre (6).
Analysis
For estimates of monthly parasite prevalence, we considered
any individual with P. falciparum parasites at any density as
infected. For each infected individual, the database was
searched for a treatment request based on their unique census
number. Once a treatment request by an infected individual
was detected, the number of days between the date on which
the positive blood film was obtained and that on which
treatment was requested was calculated. Treated cases were
defined as individuals with parasitaemia who requested
treatment during a narrow period (14 days before or after a
positive blood film was obtained) or an extended period
(28 days before or after a positive blood film was obtained).
Individuals who had parasitaemia at more than one monthly
survey were considered treated if they requested treatment
within 14 or 28 days of any positive blood film. Individuals who
did not request treatment within the above time frame were
considered untreated.
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We classified each positive blood film as a treated or
untreated episode to determine predisposing factors for
treatment uptake. The relation of the outcome (treated or
untreated) to the explanatory variables (parasite density, season
and age) was assessed by applying generalized estimating
equations (GEE) of the binomial family to the longitudinally
collected data (7). This is a generalization of the usual logistic
regression, which we used to include the effect of covariables
in the model while allowing for correlation between repeated
responses in the same individual (8). We used an unstructured
form for the within-person correlation; this allowed correla-
tions between each pair of months to be estimated separately.
Other correlation structures produced very similar results.
Sensitivity, specificity, positive predictive value and negative
predictive values of rapid malaria detection tests were
calculated as suggested by Giesecke (9). Analyses were
performed with Stata version 6 (Statacorp, Texas).
The study was approved by the ethics review boards of
the Gambian Government, Gambian Medical Research
Council Laboratories and the London School of Hygiene
and Tropical Medicine. The study methods were explained at
village meetings, and consent was given at a village level.
Individuals could refuse to participate at any time during the
study.
Results
In 1998, 1906 people lived in the four villages. The largest
ethnic groupwas theMandinka (46%); this was followed by the
Wollof (30%) and Fula (21%) groups. The remaining 3% were
Serahuli, Jolla or of unknown ethnicity.
Treatment requests
Between September 1998 and May 1999, 1620 individuals
living in a study village or a neighbouring hamlet asked for
medical care from the village health worker or the field worker.
Of these, 1150 (71%) had a temperature of 37.5 oC or higher.
Treatment was requested most frequently for children under
5 years of age (596/1620; 37%).More than half of all treatment
requests occurred during October and November (1003/
1620; 62%). Of the 1580 individuals who asked for treatment,
1209 (77%) were infected with P. falciparum; for 40 individuals,
no test results were available. The rapid detection tests
processed by the field workers in the villages had a sensitivity of
92%, specificity of 82%, positive predictive value of 90% and
negative predictive value of 85%.
Cross-sectional surveys
During the study period, 1268 individuals agreed to give
between one and nine blood samples during monthly
surveys. Their ages ranged between 8 months and 89 years
(median age 16 years). Of the 5400 thick blood films
scheduled to be collected at monthly home visits over
9 months (150 blood films 6 9 months 6 4 villages),
5226 (97%) blood films were obtained (on average, 4.1 slides
per individual). Microscopy showed P. falciparum infection in
1386/5226 (27%) slides. Overall, 726/1268 (57%) indivi-
duals had at least one P. falciparum-infected blood film. In
142/1268 (11%) individuals, the parasite density was 5000/ml
or higher. P. falciparum infected blood films were seen on two
or more sequentially obtained blood films in 232/1268 (18%)
individuals.
The monthly parasite prevalence changed with season
and age group. The parasite prevalence started to increase in
October (122/544; 22%), peaked in November (399/653;
61%) and declined in December (299/707; 42%) (Fig. 1).
Seasonal changes in parasite rates were observed in all age
groups. Children aged 5–10 years, however, had the highest
parasite prevalence throughout the follow-up period. Indivi-
duals aged over 40 years had the lowest parasite prevalence. In
parallel with the parasite prevalence, parasite densities peaked
in November, when 55/399 (14%) individuals had parasite
densities >5000/ml and 10/399 (2.5%) >50 000/ml.
Treatment requests
Of 726 individuals found to be infected with P. falciparum
during cross-sectional surveys, only 146 (20%) individuals
requested treatment at least once within a one-month window
(14 days before or after the blood sample was obtained). An
additional 53/726 (7.3%) requested treatment 14–28 days
before or 14–28 days after the positive blood film was
collected. Altogether, within two months of the collection of a
positive blood film, only 199/726 (27%) individuals with
parasitaemia requested treatment.
Treatment uptake varied significantly between villages.
Uptake was highest in Yallal, where 72/192 infected
individuals (38%, 95% confidence interval (CI) 31% to 45%)
requested treatment. Treatment uptake was lowest in Kani
Kunda, where only 6/136 infected individuals requested
treatment (4.4%, CI 1.6% to 9.4%). In the remaining two
villages (Kumbija and Bambali), 57/215 (27%, CI 21% to
33%) and 11/185 (6.0%, CI 3.0% to 10%), individuals
requested treatment, respectively.
Factors influencing treatment requests
The proportion of individuals requesting treatment was greater
in those with higher parasite density (Fig. 2). In total, 60/
142 (42%) individuals requested treatment for 61/170 epi-
sodes (36%) of parasitaemia with a parasite density of 5000/ml
or higher. Individuals with blood films with parasite densities
55000/ml were five times more likely to request treatment
than those with parasite densities <5000/ml (odds ratio 5.2, 3.6
to 7.4) (Table 1). The percentage of individuals who requested
treatment varied with age: children aged <6 years with
parasitaemia were brought for treatment most frequently
(51/168; 30%), whereas treatment was requested for only 95/
558 (17%) of children aged 56 years (odds ratio 1.8, 1.3 to
2.7). This odds ratio was not statistically significant, however,
when we adjusted for parasite density, village and month
(Table 1). Individuals who were infected during October and
November were more likely to request treatment than those
infected during the remaining months of the year (odds ratio
2.2, 1.6 to 3.2) (Table1). We did not detect any interaction
between requests for treatment and village, parasite density,
season or age. The sex of infected individuals did not influence
treatment uptake. The predisposing factors for episodes of
parasitaemia that resulted in a treatment request were similar in
the four villages.
Home treatment
After the malaria season, 120 household heads from the four
villages were asked whether they had bought any medication
for fever or kept any medication at home. In total, 15/120
(13%) reported home treatment with paracetamol and 3/120
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(2.5%) with chloroquine during the preceding malaria season.
Twenty shops in the four study villages were visited by a
fieldworker; 13 (65%) of these kept paracetamol, but only one
(5%) sold chloroquine. No other drugs with antimalarial
activity were available for sale.
Discussion
At the peak of the malaria season, more than half (61%) of the
study population were infected with P. falciparum. The highest
prevalence was found in children aged 5–10 years. These
findings are consistent with those in other regions with
seasonal malaria, such as Dielmo in Senegal (10) and Garki in
Nigeria (11).
Treatment requests
Overall, we found that only 20% of all infected individuals
sought medical treatment within the 14 days before or after a
positive blood film was obtained. Considerable variations in
treatment uptake were seen between villages. Treatment
uptakewas highest (38%) in the villagewith the highest parasite
prevalence and parasite density and lowest (4.4%) in the village
with the lowest parasite prevalence and density. Even in the
village with the highest uptake, only a third of infected
individuals requested treatment; this level of treatment is
unlikely to have an effect on transmission. The observed
heterogeneity in treatment uptake between the villages is a
source of concern. Villages with low uptake will remain a
reservoir for P. falciparum infections.
Reasons for low treatment uptake
Symptomaticity
No single explanation can account for the high level of
untreated infections. Several findings indicate that the majority
of P. falciparum infections in the study area were asymptomatic
and, therefore, were left untreated. For example, an infection
was five times more likely to result in a treatment request if the
parasite density was >5000/ml. Infections with parasite
densities <5000/ml were more likely to have been asympto-
matic and thus did not trigger a visit to a treatment centre.
Infected children aged under five years were more frequently
brought for treatment than older children or adults. Im-
munologically naive children are more likely to have high-
density parasitaemias than older individuals, however, and thus
are more likely to be symptomatic. After we adjusted for
parasite density, village and month, however, the difference in
treatment uptake with age was not statistically significant.
Infections detected duringOctober andNovember were
twice as likely to be treated as infections detected during the
rest of the year. New P. falciparum infections are most
frequently acquired during October and November — the
peak of the malaria transmission season — and they are more
likely to result in acute signs and symptoms than P. falciparum
infections detected outside the transmission season, which
may be chronic and asymptomatic in character.
Alternative treatments
Another potential reason for why so few infections were
treated by the designated health care providers is that residents
of the study villages seek treatment from alternative sources. It
is unlikely that infected individuals would have spent time and
money to obtain treatment outside their village, but anti-
malarials kept in the home for an emergency could have been a
readily available source of treatment.
The reported use of home treatment in sub-Saharan
Africa is very variable. A study conducted in Togo in 1989
found that 83% of febrile children received antimalarials at
home (12). In the United Republic of Tanzania, 72% of
respondents reported that they had treated themselves for a
suspected attack of malaria with antimalarial drugs kept at
home (13). Home treatment was found to be widespread in
Ghana in a study in 1997 (14). A recent study in Yanfolila, Mali,
found that 76% of interviewed mothers managed their child’s
disease at home using traditional and biomedical treatment
(15). Similarly, a study in Nigeria found that 71% of
interviewed mothers had used antimalarials (16). High rates
of self-treatment have been reported in rural Kenya. For
example, in 1995, 60% of the respondents in a study were
treated at home with herbal or biomedical remedies (17). More
recently, 47% of febrile children were found to have received
antimalarials at home (18). In contrast, self-treatment was not
found to be common in rural Niger, probably because of the
absence of antimalarials (19).
In an earlier survey in our study area, self-treatment was
not found to be common practice (20). We also found that
home treatment was uncommon in the study villages. Most
(85%) households denied using home treatments, and only 3/
120 reported the use of antimalarials. The apparent scarcity of
home treatment with antimalaria drugs was corroborated by
the absence of antimalarials in village shops. The questions
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about home treatment were asked at the end of the malaria
season and so underreporting due to recall bias cannot be
excluded; however, our results are consistent with a survey
conducted in 57 villages in the study area during the malaria
seasons of 1996 and 1997, which also found home treatment to
be uncommon (21). In this earlier study, only 8% of children
had received self-treatment with chloroquine and only 8% of
families kept chloroquine at home.
Aside from biomedical treatment, traditional treatments,
including herbal remedies, are widely used in the Gambia (22).
Practices vary between ethnic groups, and knowledge of the
methods in use is not easily accessible to outsiders. Only a few
households (16%) reported the use of traditional medication
for malaria treatment during the surveys done in 1996 and
1997, but observational studies might show a higher
prevalence.
Disease recognition
Signs and symptoms associated with P. falciparum infections
may not have been recognized by the patient or his or her
caregiver, and this could lead to a failure to seek treatment.
When 178 individuals were asked what kinds of complaints
people with malaria have (in appropriate local terms) during a
survey in the study area in 1999, over 90% of the respondents
were aware that fever and headache can be signs of malaria
(23). Furthermore, 84% of respondents were aware that
malaria is transmitted by mosquitoes. These findings indicate a
high level of awareness of malaria in the study area. We do not
know what percentage of patients or caregivers in the study
area can actually recognize a sign of malaria, such as fever,
which was found to determine treatment uptake in a study in
Guinea (24).
Improving treatment uptake
Two explanations for the observed low treatment uptake are
apparent. Individuals with P. falciparum infections may have no
signs and symptoms and are, therefore, unaware of their
infection. Alternatively, some infected individuals have signs
and symptoms but do not make use of the available treatment.
Further research is required to determine how often and why
individuals with signs and symptoms do not make use of
available health care.
Qualitative research could provide a better under-
standing of the barriers that prevent symptomatic individuals
from seeking biomedical treatment. Such understanding is
needed to plan interventions to improve the uptake of malaria
treatment. An example of how treatment uptake can be
improved has been demonstrated recently in Tigray, Ethiopia
(25). The approach followed was the selection and training of
mother coordinators to teach all mothers to recognize
symptoms that might be caused by malaria and to give an
appropriate course of chloroquine to children with malaria. A
statistically significant reduction of 40% in malaria-related
mortality in children under 5 yearswas observed in clusters that
had received the intervention compared with control clusters.
The teaching of mothers seems to be a promising approach, as
it is economical and acceptable for most communities.
Previous experience with community-based interventions that
increase treatment uptake in sub-Saharan Africa have had
mixed success (20, 26, 27).
Other strategies to reach untreated individuals with
asymptomatic infections need to be considered. While those
with asymptomatic infection may not be acutely aware of their
disease, they may still suffer from the long-term effects of the
infection, most obviously anaemia. Furthermore, at some stage
of their infection, individuals are likely to become gametocy-
taemic and, therefore, will maintain infections in the population.
Presumptive therapy is one approach to reducing the
prevalence of asymptomatic P. falciparum infections, as
diagnosis of each infected individual is neither feasible nor
cost-effective. In selected low-transmission scenarios, re-
peated mass administrations of antimalarials can interrupt
malaria transmission (28). A cluster, randomized, controlled
trial using a single, mass administration of artesunate combined
with pyrimethamine plus sulfadoxine given to all age groups
failed to interrupt malaria transmission in the Gambia in 1999
(29). A temporary benefit observed in treated clusters
compared with control clusters was most likely due to the
prophylactic effect of pyrimethamine plus sulfadoxine.
Administering drugs to the whole population is an
expensive undertaking, and it may be more cost-effective to
focus such an intervention on high-risk populations, such as
children and pregnant women. Recently, Schellenberg et al.
showed that presumptive, intermittent therapy is highly
effective in the reduction of malaria-related disease among
infants in a hyperendemic region of Ifakara, southern Tanzania
(30). It will be interesting to see whether this approach can be
Table 1. Factors that influence the likelihood that one of the 1386 P. falciparum infections detected in 726 individuals resulted
in a request for treatment. The relation of the outcome (treated or untreated) to the explanatory variables (parasite density, season or age)
was assessed by applying generalized estimating equations (GEE)
Variable Category n No. (%) treateda Odds ratio
Univariate analysis Multivariate analysisb
Parasite density <5000/ml 1216 105 (8.6) 1 1
55000/ml 170 61 (35.9) 7.75 (5.03 to 11.95)c 7.94 (4.92 to 12.81)
Age 56 years old 1056 107 (10.1) 1 1
<6 years old 330 59 (17.9) 2.01 (1.32 to 3.07) 1.48 (0.92 to 2.35)
Month December–September 871 62 (7.1) 1 1
October–November 515 104 (20.2) 2.50 (1.72 to 3.62) 2.51 (1.64 to 3.84)
a Number of 1386 episodes of documented P. falciparum infection that resulted in one or more treatment requests.
b Adjusted for village and the other two variables.
c Figures in parentheses are 95% confidence intervals.
794 Bulletin of the World Health Organization 2002, 80 (10)
Research
used in older age groups in the absence of an immunization
programme as a delivery system. n
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Re´sume´
Demande de traitement chez les sujets infecte´s par Plasmodium falciparum dans les zones rurales
de Gambie (Afrique de l’Ouest)
Objectif De´terminer la proportion d’infections a` Plasmodium
falciparum traite´es dans les zones rurales de Gambie.
Me´thodes Des sujets provenant de quatre villages de Gambie ont
e´te´ suivis pendant neuf mois lors de leurs visites aux agents de
sante´ de village. Des enqueˆtes paludologiques transversales
re´alise´es une fois par mois ont permis de mesurer la pre´valence des
infections a` P. falciparum. Les demandes de traitement ont e´te´
recherche´es par interrogation de bases de donne´es raccorde´es. On
a de´fini comme cas traite´s les sujets parasite´miques ayant fait une
demande de traitement pendant une pe´riode de 14 jours ou de
28 jours avant ou apre`s l’obtention d’un frottis sanguin positif.
Re´sultats La pre´valence de la parasite´mie a atteint sa valeur
maximale en novembre 1998, avec 399 sujets parasite´miques sur
653 (61 %). Elle est reste´e la plus e´leve´e pendant toute la dure´e de
l’e´tude chez les enfants de 5-10 ans. Bien que l’acce`s au traitement
soit plus facile en Gambie que dans la majeure partie de l’Afrique
subsaharienne, seuls 20 % des sujets infecte´s ont fait une demande
de traitement au cours des 14 jours pre´ce´dant ou suivant
l’obtention d’un frottis sanguin positif. Au cours de la pe´riode de
deux mois entourant l’obtention d’un frottis positif, 199 sujets
parasite´miques sur 726 (27 %) ont fait une demande de
traitement. Malgre´ la facilite´ d’acce`s aux soins, moins de la moitie´
(42 %) des sujets pre´sentant une densite´ parasitaire compatible
avec une atteinte de paludisme (>5000/ml) ont fait une demande
de traitement. La pre´sence d’une forte densite´ parasitaire et la
survenue de l’infection pendant les mois d’octobre et novembre
e´taient associe´es a` une fre´quence accrue des demandes de
traitement. L’autome´dication e´tait rare dans les villages d’e´tude : 3
chefs de famille sur 120 (2,5 %) avaient donne´ eux-meˆmes un
traitement par des antipaludiques lors de la pre´ce´dente saison
palustre.
Conclusion Un grand nombre d’infections a` P. falciparum peuvent
rester sans traitement du fait de leur nature infraclinique. Un
traitement pre´somptif intermittent peut re´duire la morbidite´ et la
mortalite´. Il est probable que toutes les infections non traite´es
n’e´taient pas asymptomatiques. Des recherches qualitatives doivent
eˆtre entreprises pour rechercher quels sont les obstacles a` la demande
de traitement, afin de planifier des interventions e´ducatives.
Resumen
Bu´squeda de tratamiento entre las personas infectadas por Plasmodium falciparum en zonas rurales
de Gambia (A´frica occidental)
Objetivo Cuantificar la proporcio´n de infecciones por Plasmo-
dium falciparum tratadas en las zonas rurales de Gambia.
Me´todos Se sometio´ a seguimiento a personas de cuatro pueblos
de Gambia durante nueve meses a trave´s de las visitas que
efectuaban a los agentes de salud de aldea. La prevalencia de la
infeccio´n por P. falciparum se midio´ mediante encuestas
transversales mensuales sobre el paludismo. Se hicieron bu´squedas
en diversas bases de datos conectadas para determinar las
solicitudes de tratamiento. Se consideraron casos tratados los
individuos con parasitemia que solicitaron tratamiento dentro de
un periodo corto o largo (14 o 28 dı´as, respectivamente) antes o
despue´s de dar positivo en un frotis de sangre.
Resultados La prevalencia del para´sito mostro´ un pico en
noviembre de 1998, momento en el que 399 de 653 (61%)
individuos tenı´an parasitemia. La prevalencia del para´sito fue
ma´xima a lo largo de todo el estudio entre los nin˜os de 5 a 10 an˜os.
Aunque el acceso al tratamiento fue mejor que en la mayorı´a del
A´frica subsahariana, so´lo el 20% de los infectados solicitaron
tratamiento me´dico como ma´ximo 14 dı´as antes o despue´s de dar
positivo en un frotis de sangre. Durante el mes anterior o posterior a
la obtencio´n de un resultado positivo, 199 de 726 individuos (27%)
con parasitemia solicitaron tratamiento. Pese al fa´cil acceso a la
atencio´n de salud, menos de la mitad (42%) de quienes
presentaban densidades de para´sitos compatibles con ataques
de paludismo ( > 5000/ml) solicitaron tratamiento. Los altos niveles
de infeccio´n y de densidad de para´sitos registrados durante los
meses de octubre y noviembre se asociaron a una mayor frecuencia
de solicitudes de tratamiento. La automedicacio´n fue poco
frecuente en las aldeas del estudio: 3 de 120 (2,5%) cabezas de
familia se habı´an tratado con antipalu´dicos en la temporada de
paludismo precedente.
Conclusio´n Muchas infecciones por P. falciparum quedan sin
tratar debido a su cara´cter subclı´nico. El tratamiento presuntivo
intermitente puede reducir la morbilidad y la mortalidad.
Probablemente no todas las infecciones no tratadas fueran
asintoma´ticas. Deberı´an emprenderse investigaciones cualitativas
para estudiar los factores que dificultan el comienzo del
tratamiento, a fin de poder planificar las intervenciones educativas.
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